🔗 Share this article

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Elimination

According to TikTok, the service has removed violative content and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

Within minutes of entering one group, a seller posted contact information, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Item Details and Costs

Within these communities, messages display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly serious medical dangers”.